Opportunistic infection outcomes in patients receiving corticosteroids for immune checkpoint inhibitor toxicity

被引：0
|
作者：
Cook, Michael [1 ]
Atkins, Michael [1 ]
机构：
[1] MedStar Georgetown Univ Hosp, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P722
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immune checkpoint inhibitor toxicity and associated outcomes in older patients with cancer
    Hayashi-Tanner, Yacki
    Polewski, Peter J.
    Gaddam, Mamatha
    Fisher, Nancy R.
    Kovacs, Attila J.
    Marinier, David E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2022, 13 (07) : 1011 - 1016
  • [2] Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
    Vigano, Marialuisa
    Wang, Lixing
    As'sadiq, Alia
    Samarani, Suzanne
    Ahmad, Ali
    Costiniuk, Cecilia T.
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [3] Impact of systemic corticosteroids on survival outcomes in patients with immune-checkpoint inhibitor enterocolitis.
    Thompson, Leah L.
    Katznelson, Ethan
    Leet, Donna E.
    Durbin, Sienna
    Yoon, Jaewon
    Park, Jin K.
    Dougan, Michael L.
    Chen, Steven T.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Antibiotic use, clinical outcomes, and systemic immune biomarkers in patients receiving immune checkpoint inhibitor therapy
    von Itzstein, Mitchell S.
    Gonugunta, Amrit S.
    Sheffield, Thomas
    Homsi, Jade
    Dowell, Jonathan E.
    Koh, Andrew Y.
    Raj, Prithvi
    Fattah, Farjana
    Basava, Vijay S.
    Park, Jason Y.
    Popat, Vinita
    Saltarski, Jessica M.
    Gloria-McCutchen, Yvonne
    Hsiehchen, David
    Ostmeyer, Jared
    Khan, Shaheen
    Xie, Yang
    Li, Quan-Zhen
    Wakeland, Edward K.
    Gerber, David E.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 168 - 168
  • [5] Immune Checkpoint Inhibitor Toxicity
    Palmieri, David J.
    Carlino, Matteo S.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [6] Immune Checkpoint Inhibitor Toxicity
    David J. Palmieri
    Matteo S. Carlino
    Current Oncology Reports, 2018, 20
  • [7] Immune Checkpoint Inhibitor Outcomes for Patients With Non-Small-Cell Lung Cancer Receiving Baseline Corticosteroids for Palliative Versus Nonpalliative Indications
    Ricciuti, Biagio
    Dahlberg, Suzanne E.
    Adeni, Anika
    Sholl, Lynette M.
    Nishino, Mizuki
    Awad, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (22) : 1927 - +
  • [8] Outcomes of melanoma patients with brain metastases receiving immune checkpoint inhibitor (ICI) therapy.
    Ardeshir-Larijani, Fatemeh
    Nelson, Ariel Ann
    Martin, Petra
    Mendiratta, Prateek
    Sloan, Andrew E.
    Choi, Serah
    Mansur, David B.
    Hoimes, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Immune Checkpoint Inhibitor Use in Sepsis: Monitoring Immune Checkpoint Inhibitor Toxicity
    Suresh, Karthik
    D'Alessio, Franco
    CRITICAL CARE MEDICINE, 2019, 47 (09) : E788 - E788
  • [10] Clonal Hematopoiesis in Patients Receiving Immune Checkpoint Inhibitor Therapy
    Singh, Abhay
    Mencia-Trinchant, Nuria
    Griffiths, Elizabeth A.
    Gravina, Matthew
    Tajammal, Rutaba
    Faber, Mark G.
    Nowak, Annmarie
    Ernstoff, Marc S.
    Yan, LunBiao
    Herr, Megan M.
    Hassane, Duane C.
    Guzman, Monica L.
    Wang, Eunice S.
    Przespolewski, Amanda
    Thota, Swapna
    BLOOD, 2020, 136
12345